PRA

Theorem names VP, EMEA

Wednesday, November 16, 2011 02:19 PM

Theorem Clinical Research, previously Omnicare Clinical Research, has named Christian Tucat vice president & general manager, Europe Middle East & Africa. In this role, Tucat will have direct accountability for sales and the P&L of Theorem’s business in these regions.

More... »

Lilly selects Prasco to market generics

Friday, October 28, 2011 11:28 AM

Prasco Laboratories has signed a marketing and distribution agreement with Eli Lilly to market the authorized generic version of ZYPREXA (olanzapine) tablets and ZYPREXA ZYDIS (olanzapine) orally disintegrating tablets, in the U.S.

More... »

Survey: Top CROs doubled workforce over past decade

Monday, October 24, 2011 08:02 AM

Over the last 10 years, the top nine global CROs have more than doubled their workforce, which now exceeds 72,000 employees, and their revenues have increased at a compound annualized rate of 11% as they increasingly play a larger and more integral role in the drug development infrastructure, according to a new Association of Clinical Research Organizations (ACRO) member survey.

More... »

PRA expands with office in Romania

Tuesday, August 23, 2011 10:47 AM

PRA, a clinical research organization, recently opened an office in Bucharest, Romania to further strengthen its coverage of the Balkan region’s burgeoning markets. The Bucharest office will also support projects in the neighboring Republic of Moldova.

More... »

PPD rumored to be in exclusive acquisition talks with D.C.-based private equity firm the Carlyle Group

Monday, August 22, 2011 08:02 AM

While many in the upper echelon of private equity investors have been courting CRO PPD, for now all but one have been shooed away: Washington, D.C.-based Carlyle Group.

More... »

PRA names VP, psychiatric and scientific affairs

Friday, August 19, 2011 11:04 AM

PRA has named Dr. Frederick T. Lewis, D.O. vice president, psychiatry and scientific affairs in its therapeutic expertise group. Lewis will provide medical and scientific support for PRA project teams and guidance to clients in all aspects of clinical drug development.

More... »

PRA on the block, too?

Monday, August 8, 2011 08:02 AM

There was much hoopla made about PPD possibly being for sale after the Wall Street Journal published a story saying as much in mid-July. But what about its smaller competitor, PRA International?

More... »

Quintiles invests $1 million in Prana Biotechnology

Tuesday, July 5, 2011 12:21 PM

Quintiles is raising its stake in Prana Biotechnology, an Australian company focused on Alzheimer’s disease and other major age-related neurodegenerative disorders, by acquiring $1 million worth of new Prana shares, according to PharmaTimes.

More... »

PRA International acquires Kinship Technologies

Friday, May 20, 2011 11:06 AM

CRO PRA International has acquired Kinship Technologies, an India-based software developer and services company. PRA will obtain Kinship's industry changing system, EXACT, and is integrating the Kinship team to accelerate the development of technology solutions to enhance PRA's service delivery and reshape trial management.

More... »

Speculation flies over Logical Therapeutics as sites report non-payment for services

Monday, April 18, 2011 08:16 AM

Multiple investigative sites have been unable to collect payment from CRO PRA International for recent work they conducted on a phase IIb/III trial for Logical Therapeutics, a Waltham, Mass.-based biotechnology company developing a non-steroidal anti-inflammatory drug (NSAID), according to several independent sources.

More... »